Connect with us

Politics

Where Ohio Gubernatorial Candidates Stand On Marijuana

Published

on

On Tuesday, Ohio voters will cast ballots in primary elections to select each party’s nominee for governor.

The candidates have been talking about marijuana reform on the campaign trail, and we’ve compiled a list detailing each major contender’s stance on the issue.

Democrats

Richard Cordray, former director of the Consumer Financial Protection Bureau

Seen by some political observers as the favorite to win the Democratic primary nomination, Cordray has been evasive about his stance on marijuana reform since announcing his candidacy in December 2017. The establishment Democrat, endorsed by Massachusetts Sen. Elizabeth Warren (D), has only gone so far as to say that he would respect Ohio voters’ decision if they opted to legalize marijuana and vowed to improve Ohio’s existing medical marijuana program—but he’s declined to clarify his personal views on reform.

“As Governor, Rich Cordray will fix the botched implementation of Ohio’s medical marijuana program to ensure that patients have access to the medicine they need in a safe and affordable manner,” spokesperson Mike Gwin told Marijuana Moment. “He also thinks that the last marijuana ballot referendum failed partly because it was a flawed proposal. He supports voters’ right to propose a new referendum and will follow the will of the voters if it comes to a vote.”

Former Ohio Supreme Court justice Bill O’Neill, one of Cordray’s challengers, offered to drop out of the race if the candidate adopted his pro-legalization stance. But asked to comment on the challenger’s proposal in December, Cordray said simply, “I don’t have anything much to say about that today,” The Statehouse News Bureau reported.

Dennis Kucinich, former U.S. House representative

Though Cordray is considered the “conventional” favorite to win the Democratic primary nomination, Kucinich is his closest competition and still stands a “good chance” of winning, Cleveland.com reported. And when it comes to the issue of marijuana legalization, the former U.S. representative stands in stark contrast to his opponent. Kucinich has campaigned on a consistently pro-legalization agenda—and co-sponsored several bills during his tenure in Congress, ranging from the legalization of agricultural hemp to ending the federal prohibition of marijuana.

In March, Kucinich announced that part of his agenda if elected governor would involve working to legalize recreational marijuana and hemp in the state, and allowing medical marijuana patients to grow cannabis for personal use. He’s also argued that expanding access to cannabis would provide pain patients with an alternative to addictive and dangerous painkillers in a state that has been hit hard by the opioid epidemic.

Bill O’Neill, former Ohio Supreme Court justice

Political analysts don’t consider O’Neill a particularly strong contender in the Democratic gubernatorial primary—due in no small part to his brazen social media posts about his past sexual escapades in the wake of misconduct allegations against former Minnesota Sen. Al Franken (D). His viability as a candidate has also been questioned given his lack of name recognition and campaign funding. That said, O’Neill has unequivocally championed marijuana reform throughout his candidacy.

His campaign website reads clearly: “Marijuana should be legal in Ohio. It has many non-addictive medicinal qualities; reduces the dependence on opioids and alcohol; and is a proven job, tax and income producer.”

Early into his run for governor, O’Neill said that he would bow out of the race if Cordray threw his hat into the ring, but he’s since said that he “wants Cordray to agree with him on marijuana legalization and reopening shuttered state mental hospitals to treat opioid addicts,” before he’s willing to exit the race. Cordray declined to comment on O’Neill’s proposal.

Joseph Schiavoni, Ohio senator

The former boxer and current state senator’s candidacy has been met with skepticism— but on at least one issue, he stands out in his adamant support for medical and recreational marijuana legalization in Ohio. He’s co-sponsored legislation in the state to provide access to cannabis for medical marijuana patients and, according to his campaign site, feels that recreational legalization “would provide needed funding to our state and allow police to focus resources on more pressing matters,” adding that any such laws would have to be passed “properly.”

“For example, we need to make sure the money this new industry generates is directed at something specific, such as Ohio’s education system. It should not just go to the state and disappear,” a statement on his campaign site reads.

Two other Democratic candidates, Paul Ray and Larry Ealy, qualified for the November ballot, but their stances on marijuana reform—among many other issues—are unknown. Ray, a candidate who is seemingly without a digital footprint and Ealy, a former exotic dancer who ran for Ohio governor in 2014, are not considered strong candidates by most conventional measures.

Republicans

Mike DeWine, Ohio attorney general

DeWine is the favorite to win Ohio’s Republican gubernatorial nomination—and he’s resistant to marijuana reform, to say the least. Just days ago, on April 20, the state’s attorney general rejected a petition that sought to fully legalize marijuana in Ohio, Cincinnati.com reported, though he explained that the move had to do with the measure’s language, not its subject matter. The attorney general also visited Colorado in October 2015 to assess how the state’s recreational marijuana system was playing out, but after witnessing the popularity of edibles in the state, he said he was “alarmed.”

Mary Taylor, Ohio lieutenant governor 

Though there are few public details about Taylor’s personal stance on medical marijuana legalization, we know at least two things: 1) she’s on the record opposing recreational legalization, and 2) she was vocal in a push to freeze approvals on marijuana grower applications in the state in December 2017 after it was discovered that a convicted drug dealer had been hired as a consultant to grade applicants.

These States Will Probably Vote On Marijuana In 2018

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.

Kyle Jaeger is Marijuana Moment's Los Angeles-based associate editor. His work has also appeared in High Times, VICE and attn.

Politics

Former FDA Chief Wants Federal Government To Regulate State Marijuana Markets

Published

on

Former Food and Drug Administration (FDA) Commissioner Scott Gottlieb said on Monday that the federal government should regulate state marijuana programs.

In his clearest comments on the issue to date, Gottlieb said in a CNBC appearance that the rise in vaping-related lung injuries underscores the need for a federal regulatory scheme that would empower agencies to impose industry standards on aspects of legal cannabis markets such as THC potency and allowable forms of consumption.

Previously, the official had been ambiguous about the extent to which the federal government should get involved, broadly arguing that vaping issues reflect a consequence of conflicting state and federal laws without specifically saying what his preferred policy fix would be. However, in an editorial for The Wall Street Journal published last week, he provided some clarification—hinting that federal drug scheduling laws should be reformed for cannabis—but still left room for interpretation.

But now, he is beginning to lay out specific details of a regulatory agenda.

Gottlieb said during the TV interview that enforcing prohibition is no longer “politically practicable” and that Congress should pass “a federal law that actually can be enforced and allow federal regulatory authorities to impose appropriate supervision.”

While he said he’s not in favor of adult-use legalization and would “like to see the recreational uses shut down entirely,” the reality is that many states have made that decision and so any federal regulatory scheme would have to include “some accommodation of that.”

“I think the time has come that we need to grapple with this at a federal level. We can’t ignore it any more.”

Asked whether states are capable of providing the types of regulations he’s calling for, Gottlieb said no because there’s a patchwork of policies across the country and states “don’t have the capacity to both police what’s being sold in their so-called legal dispensaries as well as shut down the black market.”

“I think you’re going to need federal authorities in there to do that,” he said.

Under the regulatory model Gottlieb is envisioning, FDA and other agencies such as the Drug Enforcement Administration (DEA) “could regulate what’s being sold for the potency, for the manufacturing, for the ingredients, for the claims that are being made.”

“Even if we were to federalize it and allow some form of recreational use, we could limit what can be sold, the potency of what could be sold, the forms in which it can be sold,” he said, adding that he doesn’t think vaping THC products should be allowed.

Federal agencies could impose “tighter controls on the medical claims, holding them to a higher standard and allowing some form of recreational use, probably for products that are lower concentration, that are only delivered in forms that pose less harm than vaping e-liquids,” he said.

“There’s a way to have a compromise where you allow some form of recreational access in the states that want to allow it but something that looks far different than what you have today, something that’s far less permissive than the state laws,” he said. “That’s not a great outcome in my view from a public health standpoint, but what we have now is far worse where you have a federal government not enforcing the law at all—barely enforcing the law—because they know the existing law isn’t practical, and the states not imposing any supervision because they’re incapable of doing it or they don’t want to step in in a vigorous way.”

Dietary Supplement Industry Pushes Congress To Allow CBD Product Sales

Photo courtesy of YouTube/CNBC.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Scotland’s Ruling Party Unanimously Backs Drug Decriminalization Measure

Published

on

Delegates of the Scottish National Party (SNP) unanimously approved a resolution calling for the decriminalization of drug possession and consumption on Sunday.

At a conference in Aberdeen, lawmakers representing Scotland’s largest party and the third largest in the UK Parliament argued that removing criminal penalties for drug offenses and treating addiction as a public health issue would combat an ongoing overdose crisis.

The proposed amendment to the 1971 Misuse of Drugs Act stipulates that the current law is “not fit for purpose in 21st Century Scotland” and would add a provision “to allow for decriminalization of possession and consumption of controlled drugs so that health services are not prevented from giving treatment to those that need it.”

Members of Parliament Tommy Sheppard, Ronnie Cowan and Alison Thewliss of the SNP introduced the measure.

“Our law enforcement agencies are focused on the weak and vulnerable at the bottom of the pyramid, when they should be focused on the organized criminals at the top,” Sheppard said.

He added that if the UK government declines to pursue the reform move, it should “give Scotland the ability to do it instead, because we will take the steps necessary.”

Cowan noted that many people suffering from addiction have experienced some form of trauma and are self-medicating.

“Decriminalization demystifies drugs and places them firmly in the health arena,” he said. “Drug policy is about a mindset. Decriminalization changes the mindset and by changing that you can treat people as human beings and we can start a recovery process.”

As Common Space reported, previous SNP conferences have also seen the passage of progressive drug reform amendments, including one that would establish safe consumption sites to prevent overdoses and help people transition into treatment. Advocates have expressed frustration that the UK Parliament has generally resisted such harm reduction policies.

The Labour Party announced last month that it would launch a Royal Commission dedicated to reviewing the country’s drug laws if elected to the majority.

“The UK government’s cavalier attitude towards Scotland’s drugs emergency is simply appalling,” Thewliss said. “People are dying on our streets and the risk to the general public from discarded needles and transmission of blood borne diseases is very real—yet the Tories at Westminster sit on their hands.”

Glasgow Councillor Mhairi Hunter said at the conference that “challenging the stigma around addiction means challenging the laws that criminalize addiction.”

Over in the U.S., lawmakers remain primarily focused on reforming federal marijuana laws, but talk of broader decriminalization is growing. A survey released earlier this month found that a majority of Americans (55 percent) support the policy change.

Presidential candidates such as Pete Buttigieg and Tulsi Gabbard have voiced support for decriminalization during the course of their campaigns for the Democratic nomination.

Denver and Oakland enacted policies this year focused on psychedelics decriminalization.

Majority Of Americans Support Decriminalizing All Drugs, Poll Finds

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading

Politics

Dietary Supplement Industry Pushes Congress To Allow CBD Product Sales

Published

on

Four trade associations representing the dietary supplement industry signed a letter urging federal lawmakers to take action to provide for the lawful marketing of CBD products while the Food and Drug Administration (FDA) develops its regulations.

The American Herbal Products Association, Consumer Healthcare Products Association, Council for Responsible Nutrition and United Natural Products Alliance said Congress should “pass legislation to clarify that CBD derived from the hemp plant is a lawful dietary ingredient if the dietary supplement containing the CBD meets established product safety and quality criteria.”

To do that, the groups recommended granting a limited waiver that would exempt CBD products from a provision of the Food, Drug and Cosmetic Act that would allow companies to sell CBD as dietary supplements as long as the products are derived from hemp and meet health and safety standards.

“Given the rapidly growing marketplace of products, it is crucial that Congress take quick action to clarify the legal status of hemp-derived CBD dietary supplements,” the letter states. “At the same time, it is equally essential for FDA to have the resources it needs to protect the public from unsafe CBD products.”

“These actions are urgent given the strong consumer interest in CBD, the growth in products and sales, and the need for clarity among consumers, retailers, and manufacturers about the legal status of these products,” the groups said.

Congressional action is needed, they argued, because FDA officials have indicated that the rulemaking process for CBD could take up to five years. They also expressed appreciation for agriculture spending legislation approved by a the Senate committee that would allocate $2 million to FDA to support their efforts to develop cannabidiol regulations.

“We urge Congress to go even further to include substantial new resources to enable effective FDA oversight of this fast-growing category, including funding for efficient and timely review of new dietary ingredient notifications and enforcement of existing laws governing the safety, manufacturing, and labeling of dietary supplements containing CBD,” the letter continues. “We urge that you work with FDA to determine a level of funding adequate to assure effective regulation of the CBD marketplace that does not detract from other agency enforcement priorities.”

“This is the best, most efficient, and most timely way to both set a clear regulatory framework for the marketplace and better assure consumer protection. While we can appreciate the FDA’s deliberative interest in making sure that consumers have access to safe CBD products, we are concerned that continuing to leave the marketplace without clarity and adequate oversight for an extended period of years will both endanger consumers and the bright future of the hemp-derived products they seek. Since it appears FDA is unlikely to provide a timely and effective resolution to this challenge, Congress must act.”

The dietary supplement industry is far from alone in its call for an expedited process to allow CBD products to be marketed.

A bipartisan coalition of senators—and notably, Senate Majority Leader Mitch McConnell (R-KY)—have also urged FDA to clear a path to allow for the lawful marketing of CBD products while the agency continues to develop regulations.

Read the full CBD letter from the dietary supplement industry groups below: 

Dietary Supplement Trade As… by Marijuana Moment on Scribd

Former FDA Head Floats Federal Marijuana Regulation ‘Compromise’ To Address Vaping Issue

Photo by Kimzy Nanney.

Marijuana Moment is made possible with support from readers. If you rely on our cannabis advocacy journalism to stay informed, please consider a monthly Patreon pledge.
Continue Reading
Advertisement

Stay Up To The Moment

Marijuana News In Your Inbox


Support Marijuana Moment

Marijuana News In Your Inbox

Do NOT follow this link or you will be banned from the site!